These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Risk factors for coronary heart disease in patients with schizophrenia. Gegenava M; Kavtaradze G Georgian Med News; 2006 May; (134):55-8. PubMed ID: 16783066 [TBL] [Abstract][Full Text] [Related]
23. Explaining socioeconomic inequality in mortality among South Koreans: an examination of multiple pathways in a nationally representative longitudinal study. Khang YH; Kim HR Int J Epidemiol; 2005 Jun; 34(3):630-7. PubMed ID: 15746204 [TBL] [Abstract][Full Text] [Related]
25. Effects of a telephone counseling intervention on psychosocial adjustment in women following a cardiac event. Gallagher R; McKinley S; Dracup K Heart Lung; 2003; 32(2):79-87. PubMed ID: 12734530 [TBL] [Abstract][Full Text] [Related]
26. The pravastatin inflammation CRP evaluation (PRINCE): rationale and design. Albert MA; Staggers J; Chew P; Ridker PM; Am Heart J; 2001 Jun; 141(6):893-8. PubMed ID: 11376301 [TBL] [Abstract][Full Text] [Related]
27. Are illness perceptions about coronary artery disease predictive of depression and quality of life outcomes? Stafford L; Berk M; Jackson HJ J Psychosom Res; 2009 Mar; 66(3):211-20. PubMed ID: 19232233 [TBL] [Abstract][Full Text] [Related]
28. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Carney RM; Blumenthal JA; Freedland KE; Stein PK; Howells WB; Berkman LF; Watkins LL; Czajkowski SM; Hayano J; Domitrovich PP; Jaffe AS Arch Intern Med; 2005 Jul; 165(13):1486-91. PubMed ID: 16009863 [TBL] [Abstract][Full Text] [Related]
29. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227 [TBL] [Abstract][Full Text] [Related]
30. Adverse baseline physiological and psychosocial profiles of women enrolled in a cardiac rehabilitation clinical trial. Beckie TM; Fletcher GF; Beckstead JW; Schocken DD; Evans ME J Cardiopulm Rehabil Prev; 2008; 28(1):52-60. PubMed ID: 18277832 [TBL] [Abstract][Full Text] [Related]
31. Effects of psychological and social factors on organic disease: a critical assessment of research on coronary heart disease. Krantz DS; McCeney MK Annu Rev Psychol; 2002; 53():341-69. PubMed ID: 11752489 [TBL] [Abstract][Full Text] [Related]
32. Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design. ENRICHD Investigators Psychosom Med; 2001; 63(5):747-55. PubMed ID: 11573023 [TBL] [Abstract][Full Text] [Related]
33. Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. The ENRICHD investigators. Am Heart J; 2000 Jan; 139(1 Pt 1):1-9. PubMed ID: 10618555 [TBL] [Abstract][Full Text] [Related]
34. Characteristics of socially isolated patients with coronary artery disease who are at elevated risk for mortality. Brummett BH; Barefoot JC; Siegler IC; Clapp-Channing NE; Lytle BL; Bosworth HB; Williams RB; Mark DB Psychosom Med; 2001; 63(2):267-72. PubMed ID: 11292274 [TBL] [Abstract][Full Text] [Related]
35. Psychosocial factors: role in cardiac risk and treatment strategies. Williams RB; Littman AB Cardiol Clin; 1996 Feb; 14(1):97-104. PubMed ID: 9072294 [TBL] [Abstract][Full Text] [Related]
36. Psychosocial influences on mortality of patients with coronary heart disease. Ruberman W JAMA; 1992 Jan 22-29; 267(4):559-60. PubMed ID: 1729580 [No Abstract] [Full Text] [Related]